BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1115 related articles for article (PubMed ID: 22247442)

  • 1. Epidemiology and clinical manifestations of mucormycosis.
    Petrikkos G; Skiada A; Lortholary O; Roilides E; Walsh TJ; Kontoyiannis DP
    Clin Infect Dis; 2012 Feb; 54 Suppl 1():S23-34. PubMed ID: 22247442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meeting the challenges of an emerging pathogen: the Henry Schueler 41&9 Foundation International Forum on Mucormycosis.
    Walsh TJ; Bloom BE; Kontoyiannis DP
    Clin Infect Dis; 2012 Feb; 54 Suppl 1():S1-4. PubMed ID: 22247440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucormycosis in India: unique features.
    Chakrabarti A; Singh R
    Mycoses; 2014 Dec; 57 Suppl 3():85-90. PubMed ID: 25187095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A global analysis of mucormycosis in France: the RetroZygo Study (2005-2007).
    Lanternier F; Dannaoui E; Morizot G; Elie C; Garcia-Hermoso D; Huerre M; Bitar D; Dromer F; Lortholary O;
    Clin Infect Dis; 2012 Feb; 54 Suppl 1():S35-43. PubMed ID: 22247443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fungal necrotizing fasciitis, an emerging infectious disease caused by Apophysomyces (Mucorales).
    Chander J; Stchigel AM; Alastruey-Izquierdo A; Jayant M; Bala K; Rani H; Handa U; Punia RS; Dalal U; Attri AK; Monzon A; Cano-Lira JF; Guarro J
    Rev Iberoam Micol; 2015; 32(2):93-8. PubMed ID: 25576377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uncommon mold infections in hematological patients: epidemiology, diagnosis and treatment.
    Caira M; Trecarichi EM; Mancinelli M; Leone G; Pagano L
    Expert Rev Anti Infect Ther; 2011 Jul; 9(7):881-92. PubMed ID: 21810058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective study of mucormycosis in north India: experience from a tertiary care hospital.
    Bala K; Chander J; Handa U; Punia RS; Attri AK
    Med Mycol; 2015 Apr; 53(3):248-57. PubMed ID: 25587084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The epidemiology and clinical manifestations of mucormycosis: a systematic review and meta-analysis of case reports.
    Jeong W; Keighley C; Wolfe R; Lee WL; Slavin MA; Kong DCM; Chen SC
    Clin Microbiol Infect; 2019 Jan; 25(1):26-34. PubMed ID: 30036666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First Case of Rhinocerebral Mucormycosis Caused by Lichtheimia ornata, with a Review of Lichtheimia Infections.
    Pan J; Tsui C; Li M; Xiao K; de Hoog GS; Verweij PE; Cao Y; Lu H; Jiang Y
    Mycopathologia; 2020 Jun; 185(3):555-567. PubMed ID: 32388712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary mucormycosis.
    Hamilos G; Samonis G; Kontoyiannis DP
    Semin Respir Crit Care Med; 2011 Dec; 32(6):693-702. PubMed ID: 22167397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The emerging epidemiology of mould infections in developing countries.
    Chakrabarti A; Singh R
    Curr Opin Infect Dis; 2011 Dec; 24(6):521-6. PubMed ID: 21799406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Invasive mucormycosis in children: an epidemiologic study in European and non-European countries based on two registries.
    Pana ZD; Seidel D; Skiada A; Groll AH; Petrikkos G; Cornely OA; Roilides E;
    BMC Infect Dis; 2016 Nov; 16(1):667. PubMed ID: 27832748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutaneous mucormycosis.
    Skiada A; Petrikkos G
    Skinmed; 2013; 11(3):155-9; quiz 159-60. PubMed ID: 23930354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mucormycosis in paediatric patients: demographics, risk factors and outcome of 12 contemporary cases.
    Däbritz J; Attarbaschi A; Tintelnot K; Kollmar N; Kremens B; von Loewenich FD; Schrod L; Schuster F; Wintergerst U; Weig M; Lehrnbecher T; Groll AH
    Mycoses; 2011 Nov; 54(6):e785-8. PubMed ID: 21623951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of 28 cases of mucormycosis.
    Kursun E; Turunc T; Demiroglu YZ; Alışkan HE; Arslan AH
    Mycoses; 2015 Feb; 58(2):82-7. PubMed ID: 25590855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zygomycosis in the 1990s in a tertiary-care cancer center.
    Kontoyiannis DP; Wessel VC; Bodey GP; Rolston KV
    Clin Infect Dis; 2000 Jun; 30(6):851-6. PubMed ID: 10852735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mucormycosis].
    Csomor J; Nikolova R; Sinkó J; Reményi P; Szabó Z
    Orv Hetil; 2004 Dec; 145(50):2507-13. PubMed ID: 15662750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequence of oral manifestations in rhino-maxillary mucormycosis.
    Doni BR; Peerapur BV; Thotappa LH; Hippargi SB
    Indian J Dent Res; 2011; 22(2):331-5. PubMed ID: 21891908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Laboratory diagnosis of mucormycosis].
    Garcia-Hermoso D
    Med Sci (Paris); 2013 Mar; 29 Spec No 1():13-8. PubMed ID: 23510520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Palatal mucormycosis in patients with hematologic malignancy and stem cell transplantation.
    Al Akhrass F; Debiane L; Abdallah L; Best L; Mulanovich V; Rolston K; Kontoyiannis DP
    Med Mycol; 2011 May; 49(4):400-5. PubMed ID: 21077735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 56.